tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Morikawa K et al. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. 1994 Antimicrob. Agents Chemother. pmid:7532933
Steinbach WJ et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. 2004 Antimicrob. Agents Chemother. pmid:15105118
Sun S et al. In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. 2008 Antimicrob. Agents Chemother. pmid:18056277
Ricardo E et al. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. 2014 Antimicrob. Agents Chemother. pmid:24867987
Roy J et al. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. 2002 Antimicrob. Agents Chemother. pmid:12384349
Dang W et al. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. 2017 Antimicrob. Agents Chemother. pmid:28807916
Dannaoui E et al. In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. 2009 Antimicrob. Agents Chemother. pmid:19451295
Rosenwirth B et al. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. 1994 Antimicrob. Agents Chemother. pmid:7527198
Pea F et al. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. 2008 Antivir. Ther. (Lond.) pmid:18771060
Ginestà MM et al. Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster-to-rat heart transplantation model: histological characterisation under low-dose of FK506. 2002 APMIS pmid:12583441
Kuo WW et al. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II. 2006 Apoptosis pmid:16699953
Rapak A et al. Apoptosis of lymphoma cells is abolished due to blockade of cytochrome c release despite Nur77 mitochondrial targeting. 2007 Apoptosis pmid:17701362
Kabat-Koperska J et al. The influence of exposure to immunosuppressive treatment during pregnancy on renal function and rate of apoptosis in native kidneys of female Wistar rats. 2016 Apoptosis pmid:27586504
Kemper K et al. Targeting colorectal cancer stem cells with inducible caspase-9. 2012 Apoptosis pmid:22223359
Chen D et al. Improvement of FK506 production in Streptomyces tsukubaensis by genetic enhancement of the supply of unusual polyketide extender units via utilization of two distinct site-specific recombination systems. 2012 Appl. Environ. Microbiol. pmid:22582065
Mo S et al. Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP. 2012 Appl. Environ. Microbiol. pmid:22267670
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Barreiro C and Martínez-Castro M Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). 2014 Appl. Microbiol. Biotechnol. pmid:24272367
Salehi-Najafabadi Z et al. The gamma-butyrolactone receptors BulR1 and BulR2 of Streptomyces tsukubaensis: tacrolimus (FK506) and butyrolactone synthetases production control. 2014 Appl. Microbiol. Biotechnol. pmid:24562179
Kimura T et al. N-glycosylation is involved in the sensitivity of Saccharomyces cerevisiae to HM-1 killer toxin secreted from Hansenula mrakii IFO 0895. 1999 Appl. Microbiol. Biotechnol. pmid:10091323
Song K et al. Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. 2017 Appl. Microbiol. Biotechnol. pmid:28349163
Mo S et al. Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. 2013 Appl. Microbiol. Biotechnol. pmid:23053074
Wang J et al. Comparative proteomic and metabolomic analysis of Streptomyces tsukubaensis reveals the metabolic mechanism of FK506 overproduction by feeding soybean oil. 2017 Appl. Microbiol. Biotechnol. pmid:28175948
Ordóñez-Robles M et al. Target genes of the Streptomyces tsukubaensis FkbN regulator include most of the tacrolimus biosynthesis genes, a phosphopantetheinyl transferase and other PKS genes. 2016 Appl. Microbiol. Biotechnol. pmid:27357227
Salehi-Najafabadi Z et al. Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesis. 2011 Appl. Microbiol. Biotechnol. pmid:21792593
Ma D et al. Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production. 2018 Appl. Microbiol. Biotechnol. pmid:29666890
Ordóñez-Robles M et al. Streptomyces tsukubaensis as a new model for carbon repression: transcriptomic response to tacrolimus repressing carbon sources. 2017 Appl. Microbiol. Biotechnol. pmid:28983826
Kim DH et al. Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP. 2013 Appl. Microbiol. Biotechnol. pmid:23392766
Martínez-Castro M et al. Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. 2013 Appl. Microbiol. Biotechnol. pmid:22990582
Pavan M et al. Polyomavirus associated nephropathy presenting five years after kidney transplantation. 2011 Arab J Nephrol Transplant pmid:21999857
Okudaira H et al. Control of allergic diseases by regulation of cytokine gene transcription. 1997 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M pmid:9383912
Lübbe J et al. Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? 2003 Arch Dermatol pmid:12756112
Allen A et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. 2001 Arch Dermatol pmid:11405764
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. 1996 Arch Dermatol pmid:8629845
Van Leent EJ et al. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. 1998 Arch Dermatol pmid:9681343
Passeron T et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. 2004 Arch Dermatol pmid:15381545
Bunker CB et al. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. 2004 Arch Dermatol pmid:15381566
Ehst BD and Warshaw EM Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. 2004 Arch Dermatol pmid:15313828
Sagransky MJ et al. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. 2010 Arch Dermatol pmid:21173330
Laino L and DiCarlo A Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. 2011 Arch Dermatol pmid:21690553
Eiling E et al. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. 2008 Arch Dermatol pmid:18794482
Byrd JA et al. Response of oral lichen planus to topical tacrolimus in 37 patients. 2004 Arch Dermatol pmid:15611431
Santos-Juanes J et al. Topical tacrolimus: an effective therapy for Zoon balanitis. 2004 Arch Dermatol pmid:15611442
Milingou M et al. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. 2004 Arch Dermatol pmid:15611445
Yan AC et al. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. 2010 Arch Dermatol pmid:20083693
Ciurea AM et al. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. 2010 Arch Dermatol pmid:20083712
Mikhail M et al. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. 2008 Arch Dermatol pmid:18427063
Kunstfeld R et al. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873877
Böhm M et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873890
Allen DM and Esterly NB Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. 2002 Arch Dermatol pmid:12225004